CHA2DS2-VASc score can guide the screening of atrial fibrillation - cross-sectional study in a geriatric ward

References

• Haim M, Hoshen M, Reges O, Rabi Y, Balicer R, Leibowitz M. Prospective national study of the prevalence, incidence, management and outcome of a large contemporary cohort of patients with incident non-valvular atrial fibrillation. J Am Heart Assoc. 2015;4(1):e001486. doi:10.1161/JAHA.114.00148625609415
   PubMed Web of Science ®Google Scholar
• Vanbeselaere V, Truyers C, Elli S, et al. Association between atrial fibrillation, anticoagulation, risk of cerebrovascular events and multimorbidity in general practice: a registry-based study. BMC Cardiovasc Disord. 2016;16:61. doi:10.1186/s12872-016-0371-727021333
   PubMed Web of Science ®Google Scholar
• Andersson T, Magnuson A, Bryngelsson IL, et al. All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995–2008: a Swedish nationwide long-term case-control study. Eur Heart J. 2013;34(14):1061–1067. doi:10.1093/eurheartj/ehs46923321349
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Wolf PA, D‘Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98(10):946–952.9737513
   PubMed Web of Science ®Google Scholar
• Goren A, Liu X, Gupta S, Simon TA, Phatak H. Quality of life, activity impairment, and healthcare resource utilization associated with atrial fibrillation in the US National Health and Wellness Survey. PLoS One. 2013;8(8):e71264. doi:10.1371/journal.pone.007126423951122
   PubMed Web of Science ®Google Scholar
• Marzona I, O‘Donnell M, Teo K, et al. Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies. Cmaj. 2012;184(6):E329–E336. doi:10.1503/cmaj.11117322371515
   PubMed Web of Science ®Google Scholar
• von Eisenhart Rothe A, Hutt F, Baumert J, et al. Depressed mood amplifies heart-related symptoms in persistent and paroxysmal atrial fibrillation patients: a longitudinal analysis–data from the German Competence Network on Atrial Fibrillation. Europace. 2015;17(9):1354–1362. doi:10.1093/europace/euv01825825454
   PubMed Web of Science ®Google Scholar
• Alnsasra H, Haim M, Senderey AB, et al. Net clinical benefit of anticoagulant treatments in elderly patients with nonvalvular atrial fibrillation: experience from the real world. Heart Rhythm. 2019;16(1):31–37. doi:10.1016/j.hrthm.2018.08.01630125717
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Rev Esp Cardiol (Engl Ed). 2017;70(1):50.28038729
   PubMed Web of Science ®Google Scholar
• Wojszel ZB. Geriatric Syndromes and Care Services in Late Old Age. Multidimensional Analysis on the Example of Chosen Environments of the Podlasie Region. Bialystok: Wydawnictwo Uniwersyteckie Trans Humana; 2009.
   Google Scholar
• Zungsontiporn N, Link MS. Newer technologies for detection of atrial fibrillation. BMJ. 2018;363:k3946. doi:10.1136/bmj.k402930333105
   PubMed Web of Science ®Google Scholar
• Zoni-Berisso M, Filippi A, Landolina M, et al. Frequency, patient characteristics, treatment strategies, and resource usage of atrial fibrillation (from the Italian Survey of Atrial Fibrillation Management [ISAF] study). Am J Cardiol. 2013;111(5):705–711. doi:10.1016/j.amjcard.2012.11.02623273528
   PubMed Web of Science ®Google Scholar
• Proietti M, Mairesse GH, Goethals P, et al. A population screening programme for atrial fibrillation: a report from the Belgian Heart Rhythm Week screening programme. Europace. 2016;18(12):1779–1786. doi:10.1093/europace/euw06927170000
   PubMed Web of Science ®Google Scholar
• Mahoney FI, Barthel DW. Functional evaluation: the barthel index. Md State Med J. 1965;14:61–65.
   PubMedGoogle Scholar
• Fillenbaum GG, Smyer MA. The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. J Gerontol. 1981;36(4):428–434.7252074
   PubMedGoogle Scholar
• Rodjer L, Jonsdottir IH, Rosengren A, et al. Self-reported leisure time physical activity: a useful assessment tool in everyday health care. BMC Public Health. 2012;12:693. doi:10.1186/1471-2458-12-69322920914
   PubMed Web of Science ®Google Scholar
• Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837–847. doi:10.1161/CIRCULATIONAHA.113.00511924345399
   PubMed Web of Science ®Google Scholar
• Langenberg M, Hellemons BS, van Ree JW, et al. Atrial fibrillation in elderly patients: prevalence and comorbidity in general practice. BMJ. 1996;313(7071):1534. doi:10.1136/bmj.313.7071.15348978233
   PubMed Web of Science ®Google Scholar
• Frewen J, Finucane C, Cronin H, et al. Factors that influence awareness and treatment of atrial fibrillation in older adults. QJM. 2013;106(5):415–424. doi:10.1093/qjmed/hct06023504411
   PubMed Web of Science ®Google Scholar
• Verbiest-van Gurp N, van Bladel PJM, van Kesteren HAM, Erkens PM, Stoffers H. Current practice of Dutch cardiologists in detecting and diagnosing atrial fibrillation: results of an online case vignette study. Neth Heart J. 2017;25(10):567–573. doi:10.1007/s12471-017-1010-328631211
   PubMed Web of Science ®Google Scholar
• Chiang CE, Naditch-Brule L, Brette S, et al. Atrial fibrillation management strategies in routine clinical practice: insights from the International RealiseAF Survey. PLoS One. 2016;11(1):e0147536. doi:10.1371/journal.pone.014753626800084
   PubMed Web of Science ®Google Scholar
• Saliba W, Gronich N, Barnett-Griness O, Rennert G. Usefulness of CHADS2 and CHA2DS2-VASc scores in the prediction of new-onset atrial fibrillation: a population-based study. Am J Med. 2016;129(8):843–849. doi:10.1016/j.amjmed.2016.02.02927012854
   PubMed Web of Science ®Google Scholar
• Liu FD, Shen XL, Zhao R, et al. Predictive role of CHADS2 and CHA2DS2-VASc scores on stroke and thromboembolism in patients without atrial fibrillation: a meta-analysis. Ann Med. 2016;48(5):367–375. doi:10.1080/07853890.2016.117939027153002
   PubMed Web of Science ®Google Scholar
• Tabata N, Yamamoto E, Hokimoto S, et al. Prognostic value of the CHADS2 score for adverse cardiovascular events in coronary artery disease patients without atrial fibrillation-A multi-center observational cohort study. J Am Heart Assoc. 2017;6(8). doi:10.1161/JAHA.117.006355
   Web of Science ®Google Scholar
• van Riet EE, Hoes AW, Limburg A, Landman MA, van der Hoeven H, Rutten FH. Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion. Eur J Heart Fail. 2014;16(7):772–777. doi:10.1002/ejhf.11024863953
   PubMed Web of Science ®Google Scholar
• Barrios V, Escobar C, De La Sierra A, Llisterri JL, Gonzalez-Segura D. Detection of unrecognized clinical heart failure in elderly hypertensive women attended in primary care setting. Blood Press. 2010;19(5):301–307. doi:10.3109/08037051.2010.48805120586538
   PubMed Web of Science ®Google Scholar
• Tavernier R, Wolf M, Kataria V, et al. Screening for atrial fibrillation in hospitalised geriatric patients. Heart. 2018;104(7):588–593. doi:10.1136/heartjnl-2017-31198128883032
   PubMed Web of Science ®Google Scholar